awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48309038-F9F1CADE-3376-4221-8FEE-53919227D5CD
Q48309038-F9F1CADE-3376-4221-8FEE-53919227D5CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48309038-F9F1CADE-3376-4221-8FEE-53919227D5CD
Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study.
P2860
Q48309038-F9F1CADE-3376-4221-8FEE-53919227D5CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48309038-F9F1CADE-3376-4221-8FEE-53919227D5CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e3cf5cdcc1ce84497e7f890cc3a7397dc410c57
P2860
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.